{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "bad32605",
   "metadata": {},
   "source": [
    "# RAG Pipeline Exercise\n",
    "\n",
    "In this exercise you will build and **compare two simple Retrieval-Augmented Generation (RAG) pipelines**.\n",
    "\n",
    "You will work with a small collection of PDF documents (e.g. medical guidelines) and:\n",
    "\n",
    "1. Load and chunk the PDF documents.\n",
    "2. Create a vector index using **embedding model A** (local `BAAI/bge-m3`).\n",
    "3. Create a second index using **embedding model B** (e.g. OpenAI or Gemini embeddings).\n",
    "4. Implement a simple **retriever** and an **answering function** that calls an LLM with retrieved context.\n",
    "5. Automatically **generate questions** from the documents and use them to **compare two RAG configurations**.\n",
    "\n",
    "Cells marked with `# TODO` are **for students to implement**.\n",
    "Everything else is provided scaffolding."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4ddf82e6",
   "metadata": {},
   "source": [
    "## 0. Setup & Imports"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "be93ec53",
   "metadata": {},
   "outputs": [],
   "source": [
    "# TODO (easy): skim the imports and make sure you understand what each library is used for.\n",
    "\n",
    "from dotenv import load_dotenv\n",
    "import os\n",
    "import glob\n",
    "from PyPDF2 import PdfReader\n",
    "from langchain_text_splitters import RecursiveCharacterTextSplitter\n",
    "import faiss\n",
    "from sentence_transformers import SentenceTransformer\n",
    "import pickle\n",
    "import random\n",
    "import numpy as np\n",
    "\n",
    "# LLM / API clients (we will mainly use OpenAI here; Gemini can be added as a bonus)\n",
    "from openai import OpenAI"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "68f16980",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load API keys from .env (you need to create this file once and add your keys)\n",
    "load_dotenv()\n",
    "\n",
    "deepinfra_key = os.getenv(\"DEEPINFRA_API_KEY\")\n",
    "openai_api_key = os.getenv(\"OPENAI_API_KEY\")\n",
    "google_api_key = os.getenv(\"GOOGLE_API_KEY\")\n",
    "anthropic_api_key = os.getenv(\"ANTHROPIC_API_KEY\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fba2719d",
   "metadata": {},
   "source": [
    "## 1. Load PDF documents\n",
    "\n",
    "We assume there is a `data/` folder containing one or more PDF files.\n",
    "\n",
    "**Task:** implement `load_pdfs(glob_path)` so that it:\n",
    "- Iterates over all PDF files matching `glob_path`\n",
    "- Reads them with `PdfReader`\n",
    "- Concatenates the text of all pages into **one long string**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "d8abcb21",
   "metadata": {},
   "outputs": [],
   "source": [
    "def load_pdfs(glob_path: str = \"data/*.pdf\") -> str:\n",
    "    \"\"\"Load all PDFs matching the pattern and return their combined text.\n",
    "\n",
    "    TODO:\n",
    "    - Use `glob.glob(glob_path)` to iterate over file paths\n",
    "    - For each file, open it in binary mode and create a `PdfReader`\n",
    "    - Loop over `reader.pages` and extract text with the extract_text() function\n",
    "    - Concatenate everything into a single string `text`\n",
    "    - Be robust: skip pages where `extract_text()` returns None\n",
    "    \"\"\"\n",
    "    # YOUR CODE HERE\n",
    "    text = \"\"\n",
    "    for pdf_path in glob.glob(glob_path):\n",
    "        # Open a PDF file\n",
    "        with open(pdf_path, 'rb') as pdf_file:\n",
    "            reader = PdfReader(pdf_file)\n",
    "            for page in reader.pages:\n",
    "                text += page.extract_text()\n",
    "    return text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "416c3ad0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of characters: 230592\n",
      "Preview: Asthma: diagnosis, \n",
      "moni toring and chr onic \n",
      "asthma manag emen t (BTS, \n",
      "NICE, SI GN) \n",
      "NICE guideline \n",
      "Published: 27 No vember 202 4 \n",
      "www .nice.or g.uk/guidance/ng2 45 \n",
      "© NICE 202 4. All right s reserved. Subject t o Notice of right s (https://www .nice.or g.uk/t erms-and-\n",
      "conditions#notice-of -right s).Your r esponsi bility \n",
      "The r ecommendations in t his guideline r epresent t he view of NICE, arriv ed at aft er car eful \n",
      "consideration of t he evidence a vailable. When e xercising t heir judgem\n"
     ]
    }
   ],
   "source": [
    "# Run once and inspect\n",
    "raw_text = load_pdfs(\"data/*.pdf\")\n",
    "print(\"Number of characters:\", len(raw_text))\n",
    "print(\"Preview:\", raw_text[:500])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5c0c5a14",
   "metadata": {},
   "source": [
    "## 2. Chunk the text\n",
    "\n",
    "We will split the long text into overlapping chunks.\n",
    "\n",
    "Later you can **experiment** with different `chunk_size` and `chunk_overlap` to see how it affects retrieval.\n",
    "\n",
    "**Task:** start with the given parameters, run once, then try at least one alternative configuration and note the effects."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "a4e3f802",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RAG A: 129 chunks produced, first chunk length = 1994\n",
      "RAG B: 260 chunks produced, first chunk length = 978\n"
     ]
    }
   ],
   "source": [
    "# Base configuration (RAG A)\n",
    "chunk_size_a = 2000\n",
    "chunk_overlap_a = 200\n",
    "\n",
    "splitter_a = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=chunk_size_a,\n",
    "    chunk_overlap=chunk_overlap_a\n",
    ")\n",
    "\n",
    "chunks_a = splitter_a.split_text(raw_text)\n",
    "print(f\"RAG A: {len(chunks_a)} chunks produced, first chunk length = {len(chunks_a[0])}\")\n",
    "\n",
    "# TODO (mini-experiment): change chunk_size / chunk_overlap for RAG B and compare\n",
    "chunk_size_b =    1000\n",
    "chunk_overlap_b = 100\n",
    "\n",
    "splitter_b = RecursiveCharacterTextSplitter(\n",
    "    chunk_size=chunk_size_b,\n",
    "    chunk_overlap=chunk_overlap_b\n",
    ")\n",
    "\n",
    "chunks_b = splitter_b.split_text(raw_text)\n",
    "print(f\"RAG B: {len(chunks_b)} chunks produced, first chunk length = {len(chunks_b[0])}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ec3511f4",
   "metadata": {},
   "source": [
    "## 3. Create embeddings and a FAISS index\n",
    "\n",
    "We start with **Embedding model A: `BAAI/bge-small-en`** using `sentence-transformers`. You can find a list of more models here: https://huggingface.co/spaces/mteb/leaderboard \n",
    "make sure that the models are not bigger than the one used here. Otherwise the embeddings process will take too long.\n",
    "\n",
    "Then, as an optional extension, you can build **Embedding model B** using OpenAI or Gemini and compare.\n",
    "\n",
    "To keep the exercise manageable, the base version only **requires** BGE."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "b519161f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Embedding dimensionality (A): 384\n",
      "FAISS index (A) size: 129\n"
     ]
    }
   ],
   "source": [
    "# Embedding model A (local)\n",
    "model_name_a = \"BAAI/bge-small-en\"\n",
    "embedder_a = SentenceTransformer(model_name_a)\n",
    "\n",
    "# Compute embeddings for all chunks of configuration A\n",
    "embeddings_a = embedder_a.encode(chunks_a, convert_to_numpy=True)\n",
    "\n",
    "dimensions_a = embeddings_a.shape[1]\n",
    "print(\"Embedding dimensionality (A):\", dimensions_a)\n",
    "\n",
    "index_a = faiss.IndexFlatL2(dimensions_a)\n",
    "index_a.add(embeddings_a)\n",
    "print(\"FAISS index (A) size:\", index_a.ntotal)\n",
    "\n",
    "# Persist index/chunks if you like (optional)\n",
    "os.makedirs(\"faiss\", exist_ok=True)\n",
    "faiss.write_index(index_a, \"faiss/faiss_index_a.index\")\n",
    "with open(\"faiss/chunks_a.pkl\", \"wb\") as f:\n",
    "    pickle.dump(chunks_a, f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "77271916",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "FAISS index (B) size: 260\n"
     ]
    }
   ],
   "source": [
    "# Embedding model B using OpenAI embeddings.\n",
    "\n",
    "# TODO :\n",
    "# - Use `openai_client.embeddings.create(...)` to compute embeddings for `chunks_b`\n",
    "# - Create a second FAISS index `index_b`\n",
    "# - Make sure to check the dimensionality from the first embedding vector\n",
    "\n",
    "\n",
    "openai_client = OpenAI(api_key=openai_api_key)\n",
    "response = openai_client.embeddings.create(\n",
    "     model=\"text-embedding-3-small\",\n",
    "    input=chunks_b\n",
    ")\n",
    "embeddings_b = np.array([item.embedding for item in response.data])\n",
    "dim_b = embeddings_b.shape[1]\n",
    "index_b = faiss.IndexFlatL2(dim_b)\n",
    "index_b.add(embeddings_b)\n",
    "print(\"FAISS index (B) size:\", index_b.ntotal)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "0339224e",
   "metadata": {},
   "source": [
    "## 4. Implement a simple retriever\n",
    "\n",
    "We now implement a generic retrieval function that:\n",
    "1. Embeds the query.\n",
    "2. Searches the FAISS index.\n",
    "3. Returns the corresponding text chunks.\n",
    "\n",
    "We implement it for configuration A. If you built configuration B, you can reuse the same function."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "aa6fbf82",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of retrieved chunks:  3\n",
      "Preview of first chunk:  specialist. [NICE 2017] \n",
      "1.5 M onitoring asthma c ontrol \n",
      "1.5.1 Monit or asthma contr ol at every review . In addition t o asking about sympt oms, \n",
      "check: \n",
      "• time off w ork or school due t o ast hma \n",
      "• amount of r eliever inhaler used, including a check of t he pr escription r ecord \n",
      "• number of courses of oral cor ticost eroids \n",
      "• any admissions t o hospital or att endance at an emer gency depar tment due \n",
      "to ast hma. \n",
      "If contr ol is suboptimal, see recommendation 1 .6.1 in t he section on principles \n",
      "of pharmacological tr eatment . [BTS/NICE/SIGN 202 4] \n",
      "1.5.2 Consider using a v alidat ed sympt om questionnair e (for example, t he Ast hma \n",
      "Contr ol Questionnair e, the Ast hma Contr ol Test or t he Childhood Ast hma Contr ol \n",
      "Test) at an y ast hma r eview . [BTS/NICE/SIGN 202 4] \n",
      "1.5.3 Do not use r egular peak e xpirat ory flow (PEF) monit oring t o assess ast hma \n",
      "contr ol unless t here are person-specific r easons f or doing so (f or example, when \n",
      "PEF measur ement is par t of t he personalised ast hma action plan). [BTS/NICE/\n",
      "SIGN 202 4] \n",
      "1.5.4 Consider fractional e xhaled nitric o xide (F eNO) monit oring f or adult s wit h ast hma: \n",
      "• at their r egular r eview , and \n",
      "• before and aft er changing t heir ast hma t herap y. [BTS/NICE/SIGN 202 4] Asthma: diagnosis, monit oring and chr onic ast hma management (BTS, NICE, SIGN)\n",
      "(NG2 45)\n",
      "© NICE 202 4. All right s reserved. Subject t o Notice of right s (https://www .nice.or g.uk/t erms-and-\n",
      "conditions#notice-of -right s).Page 15 of\n",
      "64For a shor t explanation of wh y the committ ee made t hese r ecommendations and ho w \n",
      "they might aff ect practice, see t he rationale and impact section on monit oring ast hma \n",
      "contr ol. \n",
      "Full details of t he evidence and t he committ ee's discussion ar e in: \n",
      "• evidence r eview L: sympt om diar y for monit oring ast hma \n",
      "• evidence r eview  M: pulmonar y function monit oring in ast hma \n",
      "• evidence r eview  N: FeNO measur es to monit or ast hma.\n"
     ]
    }
   ],
   "source": [
    "def retrieve_texts(query: str, k: int, index, chunks, embedder) -> list:\n",
    "    \"\"\"Return the top-k most similar chunks for a query.\n",
    "    - Encode the query with `embedder.encode(...)`\n",
    "    - Call `index.search(query_embedding, k)`\n",
    "    - Use the returned indices to select the chunks\n",
    "    - Return a list of strings (chunks)\n",
    "    \"\"\"\n",
    "    query_emb = embedder.encode([query], convert_to_numpy=True)\n",
    "    distances, indices = index.search(query_emb, k)\n",
    "    retrieved = [chunks[i] for i in indices[0]]\n",
    "    return retrieved\n",
    "\n",
    "# Quick sanity check\n",
    "test_query = \"What is the most important factor in diagnosing asthma?\"\n",
    "retrieved_test = retrieve_texts(test_query, 3, index_a, chunks_a, embedder_a)\n",
    "print(\"Number of retrieved chunks: \",len(retrieved_test))\n",
    "print(\"Preview of first chunk: \",retrieved_test[1])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f646fdc6",
   "metadata": {},
   "source": [
    "## 5. Implement `answer_query` using an LLM\n",
    "\n",
    "Now we build the actual RAG call:\n",
    "\n",
    "1. Use `retrieve_texts` to get top-`k` chunks.\n",
    "2. Concatenate them into a context string.\n",
    "3. Build a prompt that:\n",
    "   - shows the context\n",
    "   - asks the model to answer the user question based **only** on this context.\n",
    "4. Call the OpenAI chat completion API.\n",
    "\n",
    "This is the **core RAG function**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "0d94610c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "RAG answer: The most important factor in diagnosing asthma is conducting objective tests that can support the diagnosis, such as measuring blood eosinophil count or fractional exhaled nitric oxide (FeNO) levels, as well as spirometry and peak expiratory flow (PEF) assessments. These tests help to differentiate asthma from other causes of respiratory symptoms, even if examination results are normal.\n"
     ]
    }
   ],
   "source": [
    "def answer_query(query: str, k: int, index, chunks, embedder, client: OpenAI) -> str:\n",
    "    \"\"\"RAG-style answer: retrieve context and ask an LLM.\n",
    "\n",
    "    TODO (students):\n",
    "    - Use `retrieve_texts` to get `k` relevant chunks.\n",
    "    - Join them into a single context string.\n",
    "    - Build a chat prompt that instructs the model to answer *only* using the context.\n",
    "    - Call `client.chat.completions.create(...)` with model `\"gpt-5o-mini\"` (or similar).\n",
    "    - Return the model's answer text.\n",
    "    \"\"\"\n",
    "    retrieved_chunks = retrieve_texts(query, k, index, chunks, embedder)\n",
    "    context = \"\".join(retrieved_chunks)\n",
    "\n",
    "    # Remember: strings can be concatenated (like an addition)\n",
    "    system_prompt = (\n",
    "        \"Answer only by using the defined <context>\"\n",
    "    )\n",
    "\n",
    "    messages = [\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "        {\"role\": \"user\", \"content\": query+\"\\n\\n<context>\"+context+\"</context>\"},\n",
    "    ]\n",
    "\n",
    "    completion = client.chat.completions.create(\n",
    "        model=\"gpt-4o-mini\",\n",
    "        messages=messages\n",
    "    )\n",
    "\n",
    "    return completion.choices[0].message.content.strip()\n",
    "\n",
    "# Quick manual test\n",
    "answer = answer_query(test_query, k=3, index=index_a, chunks=chunks_a, embedder=embedder_a, client=openai_client)\n",
    "print(\"RAG answer:\", answer)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a86a92e",
   "metadata": {},
   "source": [
    "## 6. Generate questions from random chunks (automatic evaluation set)\n",
    "\n",
    "To compare two RAG configurations, we need **questions**.\n",
    "\n",
    "We will:\n",
    "- randomly sample a few chunks from the corpus,\n",
    "- ask an LLM to generate a **good question** whose answer is contained in the chunk.\n",
    "\n",
    "Then we can use these question–chunk pairs as a small evaluation set.\n",
    "\n",
    "We provide most of the implementation. Your job is mainly to:\n",
    "- inspect the code,\n",
    "- understand the prompt,\n",
    "- maybe tweak the number of chunks or retries."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "eb899fb6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Q1: What key considerations should be taken into account when managing hypertension in women who are pregnant or breastfeeding, as well as in adults of Black African or African-Caribbean descent?\n",
      "  From chunk preview: diagnosed h yper tension in line wit h the recommendations in t his guideline. F or \n",
      "women considering pr egnancy or who...\n",
      "\n",
      "Q2: What are the recommended steps for managing a child's asthma symptoms when initial treatments fail to show improvement within the trial period?\n",
      "  From chunk preview: • severe acut e episodes of difficulty br eathing and wheez e (for example, \n",
      "requiring hospital admission, or needing 2 ...\n",
      "\n",
      "Q3: What factors influence the recommendations for hypertension treatment in individuals, particularly regarding their personal preferences, cardiovascular risk, and evidence gaps for younger patients?\n",
      "  From chunk preview: depend on t he person's pr eferences and t heir individual risk of car diovascular disease. \n",
      "The r ecommendations highli...\n",
      "\n",
      "Q4: How might the new recommendations for low-dose MART (maintenance and reliever therapy) for asthma treatment impact current practices and patient outcomes, particularly in terms of cost and the management of severe exacerbations?\n",
      "  From chunk preview: regularly and r ecommended star ting t he lo w-dose MART (maint enance and r eliever \n",
      "therap y) regimen. \n",
      "How the r ecom...\n",
      "\n",
      "Q5: What are the key updates and recommendations made in the 2024 guidelines for asthma diagnosis, monitoring, and management by BTS, NICE, and SIGN?\n",
      "  From chunk preview: of uncer tainty has been r eview ed and t he relevant r ecommendations updat ed. Asthma: diagnosis, monit oring and chr ...\n",
      "\n"
     ]
    }
   ],
   "source": [
    "def generate_questions_for_random_chunks(chunks, num_chunks: int = 5, max_retries: int = 2):\n",
    "    selected_chunks = random.sample(chunks, num_chunks)\n",
    "    qa_pairs = []\n",
    "\n",
    "    for chunk in selected_chunks:\n",
    "        prompt = prompt = (\n",
    "            \"Based on the following text, generate an insightful question that covers its key content:\\n\\n\"\n",
    "            \"Text:\\n\" + chunk + \"\\n\\n\"\n",
    "            \"Question:\"\n",
    "        )\n",
    "\n",
    "        question = None\n",
    "        for attempt in range(max_retries):\n",
    "            try:\n",
    "                completion = openai_client.chat.completions.create(\n",
    "                    model=\"gpt-4o-mini\",\n",
    "                    messages=[{\"role\": \"user\", \"content\": prompt}]\n",
    "                )\n",
    "                question = completion.choices[0].message.content.strip()\n",
    "                if question:\n",
    "                    break\n",
    "            except Exception as e:\n",
    "                print(\"Error while generating question, retrying...\", e)\n",
    "\n",
    "        if question is None:\n",
    "            question = \"Error: could not generate question.\"\n",
    "\n",
    "        qa_pairs.append((chunk, question))\n",
    "\n",
    "    return qa_pairs\n",
    "\n",
    "questions = generate_questions_for_random_chunks(chunks_a, num_chunks=5, max_retries=2)\n",
    "for i, (chunk, q) in enumerate(questions, 1):\n",
    "    print(f\"Q{i}: {q}\\n  From chunk preview: {chunk[:120]}...\\n\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3fd0eaf5",
   "metadata": {},
   "source": [
    "## 7. Compare two RAG configurations\n",
    "\n",
    "Now we can:\n",
    "- Use the generated questions,\n",
    "- Answer them with RAG configuration A (BGE + chunking A),\n",
    "- (Optional) Answer them with RAG configuration B (e.g. different chunking and/or different embeddings),\n",
    "- Compare the answers qualitatively.\n",
    "\n",
    "To keep the exercise manageable, we start with config A only.\n",
    "If you implemented config B, reuse `answer_query` with `index_b`, `chunks_b`, and your second embedder."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "a292474a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Question: What key considerations should be taken into account when managing hypertension in women who are pregnant or breastfeeding, as well as in adults of Black African or African-Caribbean descent?\n",
      "Answer A: When managing hypertension in women who are pregnant or breastfeeding, as well as in adults of Black African or African-Caribbean descent, key considerations include:\n",
      "\n",
      "1. **Medication Selection**: \n",
      "   - Avoid ACE inhibitors and angiotensin II receptor antagonists in pregnant or breastfeeding women unless absolutely necessary. Discuss potential risks and benefits before prescribing.\n",
      "   - For adults of Black African or African-Caribbean descent, consider using an angiotensin II receptor blocker (ARB) instead of an ACE inhibitor as the first-line treatment.\n",
      "\n",
      "2. **Management Guidelines**:\n",
      "   - Follow specific guidelines for pregnancy-related hypertension, which are detailed in NICE's guidelines, to ensure proper treatment and monitoring.\n",
      "   - Ensure that treatment aligns with considerations for chronic kidney disease and type 2 diabetes as applicable in the adult population.\n",
      "\n",
      "3. **Patient Adherence**: \n",
      "   - Encourage adherence to prescribed medications and provide support to ensure that patients are taking their medicines as directed.\n",
      "\n",
      "4. **Dosage Optimization**:\n",
      "   - Regularly review medication effectiveness and adjust dosages as necessary, ensuring that each individual is receiving optimal, tolerated treatment.\n",
      "\n",
      "5. **Monitoring**:\n",
      "   - Conduct thorough monitoring of blood pressure and overall health, taking into account any complications that may arise in pregnant women or individuals with other comorbid conditions.\n",
      "\n",
      "These considerations will help manage hypertension effectively while considering the specific needs and risks associated with the populations mentioned.\n",
      "Source chunk preview: diagnosed h yper tension in line wit h the recommendations in t his guideline. F or \n",
      "women considering pr egnancy or who ar e pregnant or br eastf eed ...\n",
      "------------------------------------------------------------\n",
      "Question: What are the recommended steps for managing a child's asthma symptoms when initial treatments fail to show improvement within the trial period?\n",
      "Answer A: If a child's asthma symptoms do not improve during the trial period of initial treatments, the following steps are recommended:\n",
      "\n",
      "1. **Check Inhaler Technique and Adherence**: Ensure that the child is using the inhaler correctly and taking the medication as prescribed.\n",
      "   \n",
      "2. **Identify Environmental Triggers**: Investigate whether there are environmental sources contributing to the symptoms, such as mold, tobacco smoke, or indoor air pollution.\n",
      "\n",
      "3. **Review for Alternative Diagnoses**: Consider whether another diagnosis may be causing the respiratory symptoms.\n",
      "\n",
      "4. **Referral to a Specialist**: If the above checks do not explain the lack of improvement, refer the child to a specialist in asthma care.\n",
      "\n",
      "5. **Review Treatment**: If symptoms resolve after stopping ICS and SABA treatment, monitor the child after 3 months to assess if symptoms return.\n",
      "\n",
      "6. **Restart Regular ICS**: If symptoms recur or if the child experiences an acute episode requiring systemic corticosteroids or hospitalization, restart regular inhaled corticosteroids (ICS) at a low pediatric dose and titrate up if necessary, along with SABA as needed.\n",
      "\n",
      "7. **Consider Leukotriene Receptor Antagonist**: For children under 5 with uncontrolled asthma on moderate-dose ICS, consider adding a leukotriene receptor antagonist (LTRA) for an 8 to 12 week trial. If ineffective, stop the LTRA.\n",
      "Source chunk preview: • severe acut e episodes of difficulty br eathing and wheez e (for example, \n",
      "requiring hospital admission, or needing 2 or mor e courses of oral \n",
      "cort ...\n",
      "------------------------------------------------------------\n",
      "Question: What factors influence the recommendations for hypertension treatment in individuals, particularly regarding their personal preferences, cardiovascular risk, and evidence gaps for younger patients?\n",
      "Answer A: Recommendations for hypertension treatment are influenced by several factors:\n",
      "\n",
      "1. **Personal Preferences**: It is essential to discuss the person’s treatment preferences. This includes considering the individual’s feelings about medications versus lifestyle changes and ensuring their participation in the decision-making process.\n",
      "\n",
      "2. **Cardiovascular Risk**: The committee evaluated the evidence regarding the need for early treatment based on an individual’s cardiovascular risk profile, especially in subgroups such as those with type 2 diabetes or different ethnic backgrounds. The aim is to reduce cardiovascular events and improve overall quality of life.\n",
      "\n",
      "3. **Evidence Gaps for Younger Patients**: There is limited evidence specifically addressing treatment thresholds for individuals under 40 years old. The committee acknowledged this gap, agreeing that future research is necessary to better inform guidelines for younger patients with hypertension, as existing recommendations do not indicate different thresholds based on diabetes status for this age group. \n",
      "\n",
      "The committee's recommendations reflect current best practices while emphasizing the need for ongoing research to address these gaps and enhance the personalization of hypertension treatment.\n",
      "Source chunk preview: depend on t he person's pr eferences and t heir individual risk of car diovascular disease. \n",
      "The r ecommendations highlight t he impor tance of discus ...\n",
      "------------------------------------------------------------\n",
      "Question: How might the new recommendations for low-dose MART (maintenance and reliever therapy) for asthma treatment impact current practices and patient outcomes, particularly in terms of cost and the management of severe exacerbations?\n",
      "Answer A: The new recommendations for low-dose Maintenance and Reliever Therapy (MART) are likely to impact current asthma treatment practices and patient outcomes positively. Key aspects include:\n",
      "\n",
      "1. **Improved Patient Outcomes**: The evidence suggests that low-dose MART reduces the number of asthma exacerbations and hospital admissions compared to regular low-dose ICS with SABA. This improvement in clinical outcomes can lead to better overall asthma control.\n",
      "\n",
      "2. **Cost-Effectiveness**: The economic analysis indicates that MART is a more cost-effective option compared to low-dose ICS/LABA plus SABA as needed. As MART can potentially reduce severe exacerbations requiring treatment, there may be long-term cost savings for the healthcare system.\n",
      "\n",
      "3. **Simplified Treatment Regimen**: The transition to a low-dose MART regimen for patients already using ICS/formoterol inhalers may be simpler, minimizing disruptions in their care and improving adherence.\n",
      "\n",
      "4. **Flexibility in Treatment Adjustments**: If asthma control is inadequate with low-dose MART, the evidence supports increasing the maintenance dose to moderate, which can further enhance patient outcomes.\n",
      "\n",
      "5. **Challenges with Digital Inhalers**: Although digital inhalers showed improved adherence in some studies, they were not recommended for routine use due to cost concerns and potential implications for hospital admissions. This aligns with current practices and reinforces the focus on cost-effective strategies.\n",
      "\n",
      "In summary, the new MART recommendations could lead to enhanced asthma management, reduced healthcare costs, and fewer severe exacerbations, ultimately benefiting patients and healthcare providers alike.\n",
      "Source chunk preview: regularly and r ecommended star ting t he lo w-dose MART (maint enance and r eliever \n",
      "therap y) regimen. \n",
      "How the r ecommenda tions mig ht affect prac ...\n",
      "------------------------------------------------------------\n",
      "Question: What are the key updates and recommendations made in the 2024 guidelines for asthma diagnosis, monitoring, and management by BTS, NICE, and SIGN?\n",
      "Answer A: The 2024 guidelines for asthma diagnosis, monitoring, and management by BTS, NICE, and SIGN include several key updates and recommendations:\n",
      "\n",
      "1. **Updated Recommendations**: New recommendations on diagnosis, treatment, and monitoring for people with asthma have been made based on recent evidence.\n",
      "\n",
      "2. **Focus on Evidence Review**: The guidelines have reviewed areas of uncertainty, specifically regarding physiological tests and the use of inhaled corticosteroids, to provide clearer recommendations.\n",
      "\n",
      "3. **Personalized Action Plans**: The guidelines emphasize the inclusion of strategies to minimize indoor and outdoor air pollution in personalized action plans, recognizing these as common triggers for asthma exacerbation.\n",
      "\n",
      "4. **Self-Management for Children and Young People**: Changes have been made regarding self-management strategies for children and young people, reflecting new evidence on the dosing of inhaled corticosteroids.\n",
      "\n",
      "5. **Asthma Pathway Development**: An asthma pathway has been established, integrating recommendations for accurate diagnosis, control strategies, and management of acute and severe asthma attacks.\n",
      "\n",
      "6. **Integrated Approach**: The guidelines aim to unify the previously differing approaches of BTS, NICE, and SIGN to improve clarity for healthcare professionals.\n",
      "\n",
      "7. **Continued Review and Updates**: The guidelines will be continuously reviewed and updated as new evidence emerges, ensuring they remain aligned with current best practices. \n",
      "\n",
      "These updates are designed to enhance the quality of care for individuals with asthma, ultimately aiming to improve health outcomes.\n",
      "Source chunk preview: of uncer tainty has been r eview ed and t he relevant r ecommendations updat ed. Asthma: diagnosis, monit oring and chr onic ast hma management (BTS,  ...\n",
      "------------------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "def answer_generated_questions(question_tuples, k, index, chunks, embedder, client):\n",
    "    results = []\n",
    "    for chunk, question in question_tuples:\n",
    "        answer = answer_query(question, k, index, chunks, embedder, client)\n",
    "        results.append({\n",
    "            \"chunk\": chunk,\n",
    "            \"question\": question,\n",
    "            \"answer\": answer\n",
    "        })\n",
    "    return results\n",
    "\n",
    "results_a = answer_generated_questions(\n",
    "    questions,\n",
    "    k=5,\n",
    "    index=index_a,\n",
    "    chunks=chunks_a,\n",
    "    embedder=embedder_a,\n",
    "    client=openai_client,\n",
    ")\n",
    "\n",
    "for item in results_a:\n",
    "    print(\"Question:\", item[\"question\"])\n",
    "    print(\"Answer A:\", item[\"answer\"])\n",
    "    print(\"Source chunk preview:\", item[\"chunk\"][:150], \"...\")\n",
    "    print(\"-\" * 60)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2ec212b7",
   "metadata": {},
   "source": [
    "Add RAG B and create a comparison table\n",
    "\n",
    "If you implemented a second configuration (e.g. different chunking + OpenAI embeddings):\n",
    "\n",
    "1. Build `index_b` and `embedder_b`.\n",
    "2. Run `results_b = answer_generated_questions(..., index_b, chunks_b, embedder_b, client)`.\n",
    "3. For each question, compare:\n",
    "   - Which answer is more complete / specific?\n",
    "   - Which one is better grounded in the source chunk?\n",
    "4. Summarise your findings in a short **markdown cell** or a small table.\n",
    "\n",
    "---\n",
    "\n",
    "This concludes the core RAG exercise."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
